Skip to main content

Table 2 Univariate and multivariate analyses in 483 patients with ESCC

From: Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma

 

Survival (%)

Univariate analysis HR (95% CI)

P-value

Multivariate analysis HR (95% CI)

P-value

Age (years)

  

0.780

 

0.508

≤60

49.5

1.000

1.000

>60

49.5

1.075 (0.647-1.785)

1.092 (0.841-1.420)

Gender

  

0.071

 

0.384

Female

61.1

1.000

1.000

Male

47.4

1.437 (0.969-2.131)

1.197 (0.798-1.795)

Tumor location

  

0.069

 

0.189

Upper/Middle

53.6

1.000

1.000

Lower

44.0

1.262 (0.982-1.623)

1.187 (0.915-1.539)

Tumor length (cm)

  

<0.001

 

0.561

≤3

66.7

1.000

1.000

>3

42.6

2.158 (1.564-2.977)

1.116 (0.771-1.616)

Vessel involvement

  

0.001

 

0.607

Negative

52.6

1.000

1.000

Positive

32.9

1.673 (1.228-2.279)

1.088 (0.788-1.502)

Perineural invasion

  

0.028

 

0.331

Negative

51.8

1.000

1.000

Positive

39.8

1.397 (1.036-1.884)

1.168 (0.854-1.598)

Differentiation

  

0.008

 

0.015

Well/Moderate

51.9

1.000

1.000

Poor

38.6

1.507 (1.114-2.040)

1.481 (1.081-2.030)

Depth of invasion

  

<0.001

 

0.024

T1-2

68.0

1.000

1.000

T3-4

39.5

2.363 (1.746-3.199)

1.521 (1.056-2.191)

Nodal metastasis

  

<0.001

 

<0.001

Negative

65.0

1.000

1.000

Positive

29.2

2.795 (2.158-3.621)

2.105 (1.586-2.795)

NLR

  

<0.001

 

0.039

<3.5

57.7

1.000

1.000

≥3.5

35.4

1.947 (1.513-2.506)

1.339 (1.015-1.768)

PLR

  

<0.001

 

<0.001

<150

63.5

1.000

1.000

≥150

32.7

2.245 (1.735-2.904)

1.840 (1.407-2.407)

  1. CI, confidence interval; ESCC, esophageal squamouscell carcinoma; HR, hazard ratio; NLR, neutrophil lymphocyte ratio; PLR, platelet lymphocyte ratio.